{"version":"1.0","type":"link","title":"Pretreatment clinical and hematological predictors of efficacy and immune-related adverse events in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immune checkpoint inhibitors.","author_name":"Matsuura S 외","author_url":"https://prs-insight.online/author/Matsuura%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97258","thumbnail_width":1200,"thumbnail_height":630}